Wang Thomas J, Evans Jane C, Benjamin Emelia J, Levy Daniel, LeRoy Elizabeth C, Vasan Ramachandran S
Framingham Heart Study, Framingham, MA 01702-5827, USA.
Circulation. 2003 Aug 26;108(8):977-82. doi: 10.1161/01.CIR.0000085166.44904.79. Epub 2003 Aug 11.
Information is limited regarding the rates of progression to congestive heart failure (CHF) and death in individuals with asymptomatic left ventricular systolic dysfunction (ALVD). We sought to characterize the natural history of ALVD, by studying unselected individuals with this condition in the community.
We studied 4257 participants (1860 men) from the Framingham Study who underwent routine echocardiography. The prevalence of ALVD (visually estimated ejection fraction [EF]<or=50% without a history of CHF) was 6.0% in men and 0.8% in women. During up to 12 years of follow-up, rates of CHF among subjects with normal left ventricular systolic function (EF >50%, n=4128) and ALVD (n=129) were 0.7 and 5.8 per 100 person-years, respectively. After adjustment for cardiovascular disease risk factors, ALVD was associated with a hazards ratio (HR) for CHF of 4.7 (95% CI 2.7 to 8.1), compared with individuals without ALVD. An elevated risk of CHF after ALVD was observed even in individuals without prior myocardial infarction or valvular disease, with an adjusted HR of 6.5 (CI 3.1 to 13.5). Mild ALVD (EF 40% to 50%, n=78) and moderate-to-severe ALVD (EF <40%, n=51) were associated with adjusted HRs for CHF of 3.3 (CI 1.7 to 6.6) and 7.8 (CI 3.9 to 15.6), respectively. ALVD was also associated with an increased mortality risk (adjusted HR 1.6, CI 1.1 to 2.4). The median survival of ALVD subjects was 7.1 years.
Individuals with ALVD in the community are at high risk of CHF and death, even when only mild impairment of EF is present. Additional studies are needed to define optimal therapy for mild ALVD.
关于无症状左心室收缩功能障碍(ALVD)患者进展为充血性心力衰竭(CHF)和死亡的发生率,相关信息有限。我们试图通过研究社区中未经选择的患有这种疾病的个体来描述ALVD的自然病史。
我们研究了来自弗明汉姆研究的4257名参与者(1860名男性),他们接受了常规超声心动图检查。ALVD(视觉估计射血分数[EF]≤50%且无CHF病史)的患病率在男性中为6.0%,在女性中为0.8%。在长达12年的随访期间,左心室收缩功能正常(EF>50%,n = 4128)和ALVD(n = 129)的受试者中CHF的发生率分别为每100人年0.7例和5.8例。在调整心血管疾病危险因素后,与无ALVD的个体相比,ALVD与CHF的风险比(HR)为4.7(95%CI 2.7至8.1)。即使在没有既往心肌梗死或瓣膜疾病的个体中,ALVD后CHF风险也升高,调整后的HR为6.5(CI 3.1至13.5)。轻度ALVD(EF 40%至50%,n = 78)和中度至重度ALVD(EF<40%,n = 51)与CHF的调整后HR分别为3.3(CI 1.7至6.6)和7.8(CI 3.9至15.6)。ALVD还与死亡风险增加相关(调整后HR 1.6,CI 1.1至2.4)。ALVD受试者的中位生存期为7.1年。
社区中患有ALVD的个体即使仅存在轻度EF损害,也有发生CHF和死亡的高风险。需要进一步研究来确定轻度ALVD的最佳治疗方法。